LEADER 02722nam  2200625 a 450 
001 9910779289503321
005 20200520144314.0
010   $a0-309-22557-4
010   $a1-280-38023-3
010   $a9786613558145
010   $a0-309-22555-8
035   $a(CKB)2550000000102948
035   $a(SSID)ssj0000648372
035   $a(PQKBManifestationID)11442402
035   $a(PQKBTitleCode)TC0000648372
035   $a(PQKBWorkID)10617186
035   $a(PQKB)11695043
035   $a(MiAaPQ)EBC3378973
035   $a(Au-PeEL)EBL3378973
035   $a(CaPaEBR)ebr10557792
035   $a(CaONFJC)MIL355814
035   $a(OCoLC)923287520
035   $a(EXLCZ)992550000000102948
100   $a20120517d2012      uy             0
101 0 $aeng
135   $aurcn|||||||||
181   $ctxt
182   $cc
183   $acr
200 10$aAlzheimer's diagnostic guideline validation$b[electronic resource] $eexploration of next steps : workshop summary /$fDiane E. Pankevich, Theresa Wizemann, and Bruce M. Altevogt, rapporteurs ; Forum on Neuroscience and Nervous System Disorders ; Board on Health Sciences Policy, Institute of Medicine of the National Academies
210   $aWashington, D.C. $cNational Academies Press$d2012
215   $axi, 26 p. $cill
300   $aBibliographic Level Mode of Issuance: Monograph
311   $a0-309-22554-X 
320   $aIncludes bibliographical references.
330   $a"Scientific advances during the last decade now indicate that Alzheimer's disease is a continuous, progressive cognitive disease, most likely beginning many years before dementia is apparent. To discuss the next steps in validating new diagnostic guidelines for Alzheimer's disease, the IOM Forum on Neuroscience and Nervous System Disorders hosted a public workshop session at the Alzheimer's Association International Conference."--$cPublisher's description.
606   $aAlzheimer's disease$xResearch$vCongresses
606   $aAlzheimer's disease$xTreatment$vCongresses
606   $aDiagnostic imaging$vCongresses
615  0$aAlzheimer's disease$xResearch
615  0$aAlzheimer's disease$xTreatment
615  0$aDiagnostic imaging
676   $a616.8/31
701   $aPankevich$b Diane E$01534857
701   $aWizemann$b Theresa M$0890630
701   $aAltevogt$b Bruce M$01478507
712 02$aInstitute of Medicine (U.S.).$bForum on Neuroscience and Nervous System Disorders.
712 02$aInstitute of Medicine (U.S.).$bBoard on Health Sciences Policy.
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910779289503321
996   $aAlzheimer's diagnostic guideline validation$93782695
997   $aUNINA